Stockreport

CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab [Yahoo! Finance]

CYTODYN INC  (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
PDF oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, [Read more]